Multiple Sclerosis - low dose naltrexone
Links shared publicly online about this topic.
- 953total visits
Multiple Sclerosis - low dose naltrexone
View full resource at healthcentral.com
Tags: Multiple Sclerosis, Analgesic Medication, Doctor
Most Recently Shared on August 12, 2010 at 8:26 pm By:
Koni needs advice from someone with MS who uses LDN and opiates (morphine) http://t.co/1VmNDrP Plz come answer her question.
PolygenicBlog: Study Finds Higher Doses Of ADHD Drug May Disadvantage Children In The Classroom
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on March 14, 2012 at 9:14 am By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Pharmacist, PhD, Doctor, and Medical Technology
Study Finds Higher Doses Of #ADHD Drug May Disadvantage Children In The Classroom http://t.co/9Zo24lY2
EU says Novartis MS drug needs heart monitoring | Reuters
reuters.com — “LONDON/ZURICH (Reuters) - The European Medicines Agency advised doctors to continuously monitor patients for six hours after giving them a first dose of Novartis AG's multiple sclerosis drug Gilenya, casting” View full resource at reuters.com
Most Recently Shared on January 22, 2012 at 1:09 am By:
blogaceutics Health Communicator and Pharma
EU says Novartis MS drug needs heart monitoring [Reuters] http://t.co/YKZSTCXB
Patient Dies One Day After Receiving First Dose of New MS Drug
articles.mercola.com — “Research shows that the most common brain and nerve disorders, including Multiple Sclerosis, Parkinson's and Alzheimer's, are linked to brain shrinkage and a malfunctioning of the cellular energy supply. Shifting your eating habits can help make a profound difference...” View full resource at articles.mercola.com
Most Recently Shared on January 7, 2012 at 7:02 am By:
chiropractor raleigh CAM, Chiropractor, and Doctor
Eat Like a Caveman to Protect Your Brain From Shrinking http://t.co/snl9lkLy
Patient Died Soon After Taking MS Drug Fingolimod : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on December 20, 2011 at 9:35 pm By:
Bob Finn - Medical News Net Health News
FDA reports that a patient died soon after the first dose of multiple sclerosis drug fingolimod - http://t.co/0wXIZGAl
To Taper or Not to Taper: Plummeting Steroid Levels - Steroids for Relapses - Multiple Sclerosis
healthcentral.com — “After this round of steroids (four days IV total and two days already high-dose orals), I needed to make a decision. Whenever you have MS, it seems that there are always decisions to be made. This one - to use an oral steroid taper or not.” View full resource at healthcentral.com
Most Recently Shared on November 29, 2011 at 3:35 pm By:
To Taper or Not to Taper: Plummeting Steroid Levels: After a restful Thanksgiving weekend, I wanted to discuss s... http://t.co/AKsL1490
Phase 3 Trial of Lemtrada for Multiple Sclerosis - MPR
empr.com — “Sanofi and Genzyme announced positive results from CARE-MS I, a randomized, Phase 3 clinical trial comparing Lemtrada (alemtuzumab) to Rebif (high dose subcutaneous interferon beta-1a; EMD Serono) in patients with relapsing-remitting multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on October 24, 2011 at 5:30 pm By:
Phase 3 Trial of Lemtrada for Multiple Sclerosis http://t.co/1BkfHEYQ #multiplesclerosis
Neurology Article | Multiple Sclerosis
mdlinx.com — “Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance” View full resource at mdlinx.com
Most Recently Shared on August 30, 2011 at 2:04 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by... http://t.co/7HGUl5b #neuro
Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis - Ponesimod to proceed to Phase III final stage of clinical development | Reuters
reuters.com — “Actelion Pharmaceuticals Ltd / Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis - Ponesimod to proceed to Phase III final stage of” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 11:24 am By:
John Carroll Health Communicator
Actelion's IIb dose-ranging study of MS drug registers signs of efficacy, fewer new active lesions seen in MRIs. PR; http://reut.rs/qEBee9
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis - Drugs.com MedNews
drugs.com — “- 55 percent relapse rate reduction over and above high dose IFN -1a in treatment na ve MS patients - Jul 11, 2011 - Sanofi (EURONEXT SAN and NYSE SNY) and its” View full resource at drugs.com
Most Recently Shared on July 11, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sc... http://bit.ly/rh0CHK #drug
Brass and Ivory: Life with MS & RA: Finals for #Dosie Awards
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on June 24, 2011 at 6:29 pm By:
Finals for #Dosie Awards: Your popular vote placed Brass and Ivory in the finals for the 2011 Dose of Digital #D... http://bit.ly/mqn5dU
8 Multiple Sclerosis Treatments and Their Side Effects - Multiple Sclerosis
healthcentral.com — “Since 2007, high doses of intravenous corticosteroids such as methylprednisone have been the first-line treatment for the prevention of disability fro” View full resource at healthcentral.com
Most Recently Shared on June 7, 2011 at 3:10 pm By:
HealthCentral Tips Health Site
See a Slideshow of 8 Kinds of Multiple Sclerosis #Treatment & Side Effects. #multscler #multiplesclerosis http://bit.ly/keUq4S
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multiple Sclerosis Centers
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX®(interferon beta-1a) dose titration, or” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 3:05 pm By:
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multipl... http://mnt.to/3WNZ
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortium of Multiple Sclerosis Centers - Drugs.com MedNews
drugs.com — “-Data Show that Titrating AVONEX at Initiation of Treatment Reduced Severity of Flu-like Symptoms- Jun 6, 2011 - Biogen Idec (NASDAQ BIIB) today announced the f” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 2:07 pm By:
Drugs and Devices OW OW Health
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortiu... http://bit.ly/mJMKtF #drug
Effect of lamotrigine on the PR interval in healthy subjects - Dixon - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library
onlinelibrary.wiley.com — “Effect of lamotrigine on the PR interval in healthy subjects - Dixon - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on May 22, 2011 at 2:55 am By:
Edgar Avalos, MD Neurology and Health Group
High therapeutic single dose of lamotrigine prolong PR interval up to 5.11 ms in healthy subjects http://bit.ly/m8yElp
PolygenicBlog: RightHealth Daily DoseStroke “Triggers” May Surprise You
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on May 7, 2011 at 7:38 am By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Pharmacist, PhD, Doctor, and Medical Technology
RightHealth Daily Dose » Blog Archive » Stroke “Triggers” May Surprise You http://goo.gl/fb/I7DIz
Advertisement
